Revenue: As of FY2025 Q2, the actual value is USD 382.71 M.EPS: As of FY2025 Q2, the actual value is USD -0.38.EBIT: As of FY2025 Q2, the actual value is USD -93.88 M.<h3>SHOP Segment</h3><ul><li>Revenues: $327,545 for Q2 2025, up from $308,522 in Q2 2024. $655,851 for the six months ended June 30, 2025, up from $616,648 in the same period in 2024.</li><li>Net Operating Income (NOI): $36,615 for Q2 2025, up from $28,984 in Q2 2024. $73,443 for the six months ended June 30, 2025, up from $53,694 in the same period in 2024.</li><li>Occupancy: 80.6% as of June 30, 2025, up from 79.0% as of June 30, 2024.</li><li>Average Monthly Rate: $5,440 for Q2 2025, up from $5,161 in Q2 2024.</li></ul><h3>Medical Office and Life Science Portfolio Segment</h3><ul><li>Revenues: $48,056 for Q2 2025, down from $54,555 in Q2 2024. $97,819 for the six months ended June 30, 2025, down from $108,704 in the same period in 2024.</li><li>Net Operating Income (NOI): $26,487 for Q2 2025, down from $30,273 in Q2 2024. $53,343 for the six months ended June 30, 2025, down from $60,525 in the same period in 2024.</li><li>Occupancy: 82.9% as of June 30, 2025, up from 81.5% as of June 30, 2024.</li></ul><h3>All Other Segment</h3><ul><li>Revenues: $7,111 for Q2 2025, down from $8,315 in Q2 2024. $15,906 for the six months ended June 30, 2025, down from $16,816 in the same period in 2024.</li><li>Net Operating Income (NOI): $7,030 for Q2 2025, down from $8,070 in Q2 2024. $15,884 for the six months ended June 30, 2025, down from $16,280 in the same period in 2024.</li></ul><h3>Consolidated Metrics</h3><ul><li>Total Revenues: $382,712 for Q2 2025, up from $371,392 in Q2 2024. $769,576 for the six months ended June 30, 2025, up from $742,168 in the same period in 2024.</li><li>Total Net Operating Income (NOI): $70,132 for Q2 2025, up from $67,327 in Q2 2024. $142,670 for the six months ended June 30, 2025, up from $130,499 in the same period in 2024.</li><li>Net Loss: $91,639 for Q2 2025, down from $97,861 in Q2 2024. $100,625 for the six months ended June 30, 2025, down from $184,120 in the same period in 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is encouraged by positive trends in its SHOP segment, including increases in rates, margins, and occupancy. They expect favorable supply and demand dynamics in the senior living industry to enable managers to continue to grow occupancy and drive positive performance. The company is closely monitoring the impacts of current economic and market conditions on all aspects of its business, including uncertainties surrounding interest rates and inflation, volatility in the public debt and equity markets, global geopolitical hostilities and tensions, economic uncertainties, and tariffs, labor market conditions, and changes in real estate utilization.</li></ul>

Diversified Healthcare Pref Share DHCNL 6.25 02/01/46 | 10-Q: FY2025 Q2 Revenue: USD 382.71 M